Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Earlier this month, the U.S. Food and Drug Administration proposed food companies use new, front-of-package labels highlighting the levels of fat, salt and added sugar in their products.

According to Trace One, when factoring in eating habits, food insecurity rates, alcohol consumption, and the prevalence of ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Obesity experts have thrown aside their BMI charts as they reveal it is possible to be both fat and fit. Huge numbers of the 17.6million Brits who have been told that they are overweight are in ...

President Trump’s health secretary nominee, Robert F. Kennedy Jr., on Wednesday said vaccines are a critical component of ...

Chart: The Economist By coincidence (they started ... have developed a better way of diagnosing obesity—one that distinguishes when it has become pathological. To diagnose their newly defined ...